Department of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; Institute of Precision Medicine, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Department of Urology, Affiliated Jiangmen Hospital, Sun Yat-sen University, Jiangmen, Guangdong, China.
Genomics. 2021 Mar;113(2):740-754. doi: 10.1016/j.ygeno.2021.01.016. Epub 2021 Jan 28.
Clear-cell renal cell carcinoma (ccRCC) carries a variable prognosis. Prognostic biomarkers can stratify patients according to risk, and can provide crucial information for clinical decision-making. We screened for an autophagy-related long non-coding lncRNA (lncRNA) signature to improve postoperative risk stratification in The Cancer Genome Atlas (TCGA) database. We confirmed this model in ICGC and SYSU cohorts as a significant and independent prognostic signature. Western blotting, autophagic-flux assay and transmission electron microscopy were used to verify that regulation of expression of 8 lncRNAs related to autophagy affected changes in autophagic flow in vitro. Our data suggest that 8-lncRNA signature related to autophagy is a promising prognostic tool in predicting the survival of patients with ccRCC. Combination of this signature with clinical and pathologic parameters could aid accurate risk assessment to guide clinical management, and this 8-lncRNAs signature related to autophagy may serve as a therapeutic target.
透明细胞肾细胞癌 (ccRCC) 的预后存在差异。预后生物标志物可以根据风险对患者进行分层,并为临床决策提供关键信息。我们在 The Cancer Genome Atlas (TCGA) 数据库中筛选了一个自噬相关的长非编码 lncRNA(lncRNA)标志物,以改善术后风险分层。我们在 ICGC 和 SYSU 队列中验证了该模型是一个显著且独立的预后标志物。Western blot、自噬通量测定和透射电子显微镜用于验证 8 个与自噬相关的 lncRNA 的表达调控会影响体外自噬流的变化。我们的数据表明,与自噬相关的 8-lncRNA 标志物是预测 ccRCC 患者生存的有前途的预后工具。该标志物与临床和病理参数的联合使用有助于准确的风险评估,以指导临床管理,并且该自噬相关的 8-lncRNAs 标志物可能成为治疗靶点。